Compounds > methyl 5-aminolevulinate
Page last updated: 2024-09-04

methyl 5-aminolevulinate and Mouth Neoplasms

methyl 5-aminolevulinate has been researched along with Mouth Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YK; Cheng, KH; Chi, TC; Hu, CS; Huang, WL; Wang, YM; Wang, YY; Xiao, LY; Yuan, SF1
Calin, MA; Calin, MR; Neagu, M; Petrescu, E1

Other Studies

2 other study(ies) available for methyl 5-aminolevulinate and Mouth Neoplasms

ArticleYear
MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death.
    Oral diseases, 2019, Volume: 25, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Autophagosomes; Autophagy; Body Weight; Cell Line, Tumor; Cell Survival; Cricetinae; Humans; Male; Microtubule-Associated Proteins; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Sequestosome-1 Protein; Signal Transduction; Tumor Burden

2019
Increased number of fractionated irradiation sessions does not improve the cellular response to methyl aminolevulinate-mediated photodynamic therapy.
    Photodiagnosis and photodynamic therapy, 2013, Volume: 10, Issue:4

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Mouth Neoplasms; Photochemotherapy; Radiotherapy Dosage; Treatment Outcome

2013